A Clinical Trial of Telehealth Treatment for Opioid Use Disorders

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened
    • Start date changed from estimate of Aug 15, 2026 to Sep 11, 2026
    • Eligibility criteria expanded, about 9 words
    • Site details revised
  2. Start date: Jun 1, 2026 to Aug 15, 2026
    • Collaborators: 1 to 2
    v5
  3. Primary endpoint(s) modified
    • Start date: Apr 15, 2026 to Jun 1, 2026
    • Secondary endpoints: 3 to 4
    • Eligibility criteria shortened, about 2 words
    v4
  4. Start date: Feb 2026 to Apr 15, 2026
    • Primary completion date: Jan 2028 to Oct 1, 2027
    • Study completion date: Mar 2028 to Dec 1, 2027
    v3
  5. Study completion date: Jan 2028 to Mar 2028v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yale University
490 trials monitored
See 31 trials at risk
This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Trial Details
NCT Number NCT07362082
Lead Sponsor Yale University
Collaborators: National Institute on Drug Abuse (NIDA), City University of New York, School of Public Health
Conditions
(from sponsor)		 Opioid Use Disorder
Related terms Opioid-Related Disorders
Enrollment 470 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov